Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125626432 | 12562643 | 2 | F | 20160825 | 20160715 | 20160906 | EXP | US-SA-2016SA127518 | AVENTIS | 68.00 | YR | E | F | Y | 98.40000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125626432 | 12562643 | 1 | PS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | U | UNK | 21081 | |||||||||
125626432 | 12562643 | 2 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:45 UNIT(S) | U | 6F2917A | 21081 | QD | |||||||
125626432 | 12562643 | 3 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | U | UNK | 21081 | QD | |||||||
125626432 | 12562643 | 4 | C | SOLOSTAR | DEVICE | 1 | 6F2917A | 0 | QD | ||||||||||
125626432 | 12562643 | 5 | C | SOLOSTAR | DEVICE | 1 | 0 | ||||||||||||
125626432 | 12562643 | 6 | C | PENICILLIN | PENICILLIN | 1 | 0 | ||||||||||||
125626432 | 12562643 | 7 | C | CEFTUM | CEFUROXIME | 1 | 0 | ||||||||||||
125626432 | 12562643 | 8 | C | KEFLEX | CEPHALEXIN | 1 | 0 | ||||||||||||
125626432 | 12562643 | 9 | C | CODEINE | CODEINE | 1 | 0 | ||||||||||||
125626432 | 12562643 | 10 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125626432 | 12562643 | 1 | Type 2 diabetes mellitus |
125626432 | 12562643 | 2 | Type 2 diabetes mellitus |
125626432 | 12562643 | 3 | Type 2 diabetes mellitus |
125626432 | 12562643 | 4 | Type 2 diabetes mellitus |
125626432 | 12562643 | 5 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125626432 | 12562643 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125626432 | 12562643 | Cerebrovascular accident | |
125626432 | 12562643 | Limb discomfort | |
125626432 | 12562643 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125626432 | 12562643 | 2 | 201604 | 0 | ||
125626432 | 12562643 | 3 | 2016 | 0 | ||
125626432 | 12562643 | 4 | 201604 | 0 |